Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye

International Ophthalmology

Volumn 21, Issue 4, 1997, Pages 229-234

  Larsen, Michael ^a,c   Engler, Claus B ^a   Haim, Marianne ^b   Lund Andersen, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b National Eye Clinic for the Visually Impaired Denmark   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood retina barrier; Flourescein; Fluorophotometry; Flurescein glucuronide; Healthy subjects; Pharmacokinetics; Retina; Retinitis pigmentosa; Vitreous fluorometry

Indexed keywords

FLUORESCEIN; FLUORESCEIN GLUCURONIDE; TRACER;

ADULT; ARTICLE; BLOOD RETINA BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPID MEMBRANE; LIPID SOLUBILITY; MALE; PERMEABILITY BARRIER; RETINITIS PIGMENTOSA; SPECTROFLUOROMETRY;

ADULT; BLOOD-RETINAL BARRIER; FEMALE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FLUORESCEINS; FLUOROPHOTOMETRY; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PERMEABILITY; RETINITIS PIGMENTOSA; SOLUBILITY;

EID: 0031397365     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006044107353     Document Type: Article

References (13)

1. Dalgaard P, Barker VA, Lund-Andersen H, 1989. Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci 30: 1522-1526.
2. Dalgaard P, Larsen M, 1990. Fitting numerical solutions of differential equations to experimental data: a case study and some general remarks. Biometrics 46: 1097-1109.
3. Engler CB, Sander B, Larsen M, Dalgaard P, Lund-Andersen H, 1994a. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Acta Ophthalmol 72: 655-662.
4. Engler CB, Sander B, Larsen M, Koefoed P, Parving H-H, Lund-Andersen H. 1994b. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Acta Ophthalmol 72: 663-667.
5. Grotte D, Mattox V, Brubaker R, 1985. Fluorescent, physiological, and pharmacokinetic properties of fluorescein glucuronide. Exp Eye Res 40: 23-33.
6. Kitano S and Nagataki S, 1986. Transport of fluorescein monoglucuronide out of the vitreous. Invest Opthalmol Vis Sci 27: 998-1001.
7. Koyano S, Araie M, Eguchi S, 1993. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid. Invest Ophthalmol Vis Sci 34: 531-538.
8. Larsen M, Dalgaard P, Lund-Andersen H, 1991a. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability of fluorescein and fluorescein glucuronide. Graefe's Arch Clin Exp Ophthalmol 229: 350-357.
9. Larsen M, Dalgaard P, Lund-Andersen H, 1991b. Determination of spatial coordinates in ocular fluorometry. Graefe's Arch Clin Exp Ophthalmol 229: 358-362.
10. Larsen M, Loft S, Hommel E, Lund-Andersen H, 1988. Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein. Acta Ophthalmol 66: 427-432.
11. Larsen M, Lund-Andersen H, 1991. Lens fluorometry: light attenuation effects and estimation of total lens transmittance. Graefe's Arch Clin Exp Ophthalmol 229: 363-370.
12. Lund-Andersen H, Krogsaa B, la Cour M, Larsen J, 1985. Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Opthalmol Vis Sci 26: 698-710.
13. Mallick KS, Zeimer RC, Fishman GA, Blair NP, Anderson RJ, 1984. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa. Arch Ophthalmol 102: 691-696.